Doxorubicin promotes NK cell dysfunction and induces acute liver injury through kynurenine-AhR axis
International Immunopharmacology · 2025-04 · 153 · 114489
DOI: 10.1016/j.intimp.2025.114489 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-04. Verfasst von Bohuai Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China. Hauptthemen laut MEDLINE: Kynurenine, Chemical and Drug Induced Liver Injury, Doxorubicin, Killer Cells, Natural. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fujian Provincial Natural Science Foundation, Fujian Medical University.
Abstract (Originalsprache)
Drug-induced liver injury (DILI) is one of the significant drug-induced diseases and a major cause of clinically unexplained liver injury and unexplained liver diseases. However, the mechanisms underlying doxorubicin (DOX)-induced DILI remain unclear. In this study, we constructed a mouse model of DOX-induced acute liver injury (ALI) and employed a combination of proteomics, metabolomics, and flow cytometry (FCM) to examine the roles of metabolic processes and innate immune responses. Our findings revealed that DOX treatment altered the metabolic profile and innate immune response signals in mouse livers. Specifically, DOX activated the indoleamine 2,3-dioxygenase 2 (IDO2)-mediated L-Tryptophan/L-Kynurenine metabolic pathway. Further in-depth analysis demonstrated that DOX promoted natural killer (NK) cell dysfunction leading to ALI by activating the kynurenine-aryl hydrocarbon receptor (Kyn-AhR) axis. Importantly, targeting the Kyn-AhR axis could reverse DOX-induced ALI. In summary, this study suggests that targeting the Kyn-AhR axis holds promise as an effective strategy to reverse ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China.
- Department of Cardiovascular, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350004, China.
- Public Technology Service Center, Fujian Medical University, Fuzhou, 350122, China.
- Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China. Electronic address: wulinqing@fjmu.edu.cn.
- Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China. Electronic address: wangzengbin@fjmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Fujian Provincial Natural Science Foundation
- Fujian Medical University
- Department of Education, Fujian Province
Zitieren
APA
Tang, B., Ouyang, H., Zheng, S., Yu, L., Xiao, R., Wu, L., & Wang, Z. (2025). Doxorubicin promotes NK cell dysfunction and induces acute liver injury through kynurenine-AhR axis. International Immunopharmacology, 153, 114489. https://doi.org/10.1016/j.intimp.2025.114489
Vancouver
Tang B, Ouyang H, Zheng S, Yu L, Xiao R, Wu L, et al. Doxorubicin promotes NK cell dysfunction and induces acute liver injury through kynurenine-AhR axis. International Immunopharmacology. 2025;153:114489. doi:10.1016/j.intimp.2025.114489
BibTeX
@article{Tang2025,
author = {Tang, Bohuai and Ouyang, Huan and Zheng, Shuping and Yu, Le and Xiao, Ruiying and Wu, Linqing and Wang, Zengbin},
title = {Doxorubicin promotes NK cell dysfunction and induces acute liver injury through kynurenine-AhR axis},
journal = {International Immunopharmacology},
year = {2025},
volume = {153},
pages = {114489},
doi = {10.1016/j.intimp.2025.114489}
}
EUVIMED